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Many patients die awaiting heart transplantation (CTX) due to a shortage of
donor hearts. There remains an urgent need to identify those at greatest risk
of dying during the waiting period so that priority for CTX can be optimally as-
signed. Because interlead variability of OT intervals (OT dispersion) has been
shown to identify arrhythmia or sudden death risk in certain populations,
this prospective study was undertaken to determine whether OT dispersion
might predict death in patients awaiting CTX. Of 108 consecutive patients
referred for CTX evaluation, 80 were placed on a waiting list, at which time a
standard 12-lead electrocardiogram (ECG) was recorded. OT dispersion was
measured as either the maximum-minimum OT interval (OTDISP) or as the
coefficient of variation of all OT intervals (OTCV). Patients were followed for
up to 25 months (mean time on waiting list 201 days). Annualized mortality
was 27% (7 heart failure and 7 sudden deaths), with 18% of patients dying
within 6 months. Using Cox regression analysis, only 3 variables identified at
the time of wait-listing predicted subsequent pre-transplant mortality; older
age (p < 0.04), OTDISP (p = 0.015) and OTCV (p = 0.004). Even the simplest
measurement of OT variability, (OTDISP), which could be rapidly obtained
from a standard 12-lead ECG, predicted a 4.5-fold increase in mortality in
those patients whose OTDISP exceeded 120 msec. (95% confidence inter-
val 1.1 to 17.8). Gender, etiology of heart failure, NYHA class, heart rate,
presence of a bundle branch block, or left ventricular ejection fraction (mean
19%) did not predict risk. Conclusion: Indices of OT dispersion provide a
powerful means to stratify a patient's risk of dying while awaiting CTX, and
may help to establish priority on a CTX waiting list.
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QT Dispersion Measured at the Time of Wait-Listing
is a Powerful Predictor of Who will Die Awaiting
Heart Transplantation
David J. Pinsky, Robert R. Sciacca, Jonathan S. Steinberg. Columbia University and
St. Luke 's-Roosevelt Hospital Center, New York, NY
As the waiting list for donor hearts increases, innovative ways to expand the
donor pool are being utilized. For urgent status I and older age recipients
(ages 60-70 years), we have been using donor hearts with normal left ven-
tricular function but with pre-existing coronary artery disease and performing
saphenous vein bypass grafts (SVG) at the time of transplantation. We now
report our short term results. Between March 1992 and June 1994, 10 pa-
tients (5 urgent status I with mean age 50.4 years and 5 older age patients
with mean age 65.4 years) underwent cardiac transplantation in our institu-
tion having either 1,2 or 3 SVGs performed at the time of transplant surgery.
The mean donor age was 54.2 years. Six of 10 patients have survived to 1
year with 3 early deaths and 1 late death due to infection (2 patients), rejec-
tion and early graft failure. Autopsies revealed all SVGs to be patent in all 4
patients. At the first year coronary angiogram, 9 of 10 SVGs (in 6 patients)
were found to be patent without significant stenoses present. Cardiac func-
tion at 1 year after transplant was as follows:
Average Cardiac Function at 1 year post OHT
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Outcome of Patients Transplanted with Bypassed
Donor Hearts
Hillel Laks, Davis Drinkwater, Jon A. Kobashigawa, Michael P. Gleeson. UCLA
Medical Center, Los Angeles, CA
The profound shortage of organ donors continues to fuel the search for other
methods to refurbish a failing heart. The use of transgenic cells transplanted
(Tx) in syngeneic rodents has shown modest success, but allogeneic and
xenogeneic transplants have not been uniformly successful. To assess the
feasibility of xenogeneic and allogeneic myoblast transplantation, six adult
swine underwent transplantation of murine atrial tumor cells (Xenogeneic)
and neonatal porcine myocytes (Allogeneic) into the left ventricular wall. Fol-
lowing general anesthesia, isolated cells were injected along the anterior and
posterior wall ofthe porcine left ventricle (six sites per animal). All the animals
were immunosuppressed with cyclosporine and prednisone and were fol-
lowed for 1 month post-injection and then sacrificed. Results are as follows:
In all 36 injected sites, the Tx cells proliferated within the host myocardium
with no significant rejection. CPK MB did not increase after the procedure
indicating that there was no damage to the host myocardium from the in-
jection of cells. Moreover, Tx cells formed close associations with host my-
ocytes that resembled intercalated discs on electron microscopy, and were
composed of PAN cadherin on immunofluorescent staining. These cells also
contained myofibrils and other cell architecture that resembled normal AT-l
or neonatal myocytes. Additionally, these cells produced angiogenic factors
resulting in a proliferation of the surrounding microvasculature. In conclu-
sion, these findings indicate successful xenogeneic and allogeneic myocyte
cell transplantation in a large animal model. These experiments set the stage
for future studies testing the ability of these cells to form a syncitium, con-
tract, and thereby "repair" a damaged heart.
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Successful Transplantation of Myoblasts into Adult
Porcine Myocardium: A Potential Method to Repair a
Failing Heart
Frank W. Smart, William Claycomb, Joseph DelCarpio, Duane Smith, Hector
O. Ventura, Mandeep R. Mehra, Dwight D. Stapleton, Helen DeGruiter, R.
Wayne Barbee, Clifford H. Van Meter. Ochsner MedicallnsMutions and Louisiana
State University School of Medicine, New Orleans, LA
was lower with TOHT vs SOHT at both time intervals (7 ± 4 vs 9 ± 4, P =
0.02 and 5 ± 2 vs 7 ± 3, P = 0.0006). Pulmonary arterial (PAM) and left atrial
mean pressure (PCWP) (mmHg) were similar at 2 weeks (21 ± 6 vs 23 ± 6,
P = NS; 12 ± 5 vs 13 ± 5, P = NS). At 6 months PAM was similar (20 ± 7
vs 22 ± 6, P ~ NS) but PCWP was lower in the TOHT group (11 ± 5 vs 13 ±
5, p = 0.045). Pulmonary vascular resistance (PVR, Wood-Units) was similar
at 2 weeks (16 ± 0.7 vs 1.9 ± 1.0, P = NS) and 6 months (1.6 ± 0.7 vs 1.7
± 1.0, P = NS). Heart rate (bpm) was higher at 2 weeks and 6 months with
TOHT than SOHT (84 ± 10 vs 75 ± 12, P = 0.0003 and 90 ± 12 vs 82 ± 9,
P = 0.0006). Conclusions: Despite a longer ischemic time, total orthotopic
heart transplantation does not impair postoperative cardiac function. There
is an early improvement in cardiac output, a sustained higher heart rate re-
flecting preservation of donor sinus node function, and a lower RA pressure,
perhaps due to less tricuspid regurgitation.
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Induction of Inducible Nitric Oxide Synthase (iNOS)
mRNA and Protein in the Human Cardiac Allograft is
Associated with Increased Myocardial cGMP Levels
and Echocardiographlc LV Dysfunction
Neil P. Lewis, Philip S. Tsao, Peter R. Rickenbacher, Guy A. Haywood, Heiko von
der Leyen, Sharon A. Hunt. Margaret E. Billingham 1, Hannah A. Valantine, Michael
B. Fowler. Cardiovascular Medicine, Stanford University, Stanford, CA; 1Pathology,
Stanford University, Stanford, CA
In humans the mechanisms underlying LV contractile dysfunction following
cardiac transplantation remain poorly defined. iNOS is expressed in the rat
heterotopic cardiac allograft during rejection; the resultant overproduction
of nitric oxide (NO) might contribute to cardiac contractile dysfunction via
cGMP-mediated negative inotropic actions, or by the cytotoxic actions of
NO. We therefore prospectively studied 16 patients at surveillance endomy-
ocardial biopsy during the first year posttransplant - a total of 123 biopsies
(4-12 sequential per patient). iNOS mRNA was detected by reverse transcrip-
tion PCR in biopsy allograft myocardium in every patient, and in 59/123 (48%)
biopsies overall. iNOS mRNA expression was episodic and time dependent;
expression was most frequent during the first 180 days posttransplant (p =
0.0006). iNOS expression was not related to the ISHLT histologic grade of re-
jection. iNOS protein was detected by immunofluorescence in the coronary
microvasculature and in cardiac myocytes; expression was associated with
increased myocardial cGMP levels (p = 0.01) and with systolic (p = 0.024)
and diastolic (p = 0.006) left ventricular contractile dysfunction measured by
echocardiography and Doppler.
Conclusion. These data support a causal relationship between iNOS ex-
pression and myocardial contractile dysfunction in the human cardiac allo-
graft.
Conclusion: Patients transplanted with bypassed donor hearts appear to
have normal cardiac function and acceptable short term survival considering
their preop high risk status. A majority of SVGs remain patent at 1 year with
coronary ischemia not appearing to be responsible for early mortality.
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1734-1 I Interim Analysis of the EPISODE Trial
Elma J. Gussenhoven, EPISODE study group. University Hospital Rotterdam-Dijkzigt
The Netherlands Heart Foundation and the Interuniversity Cardiology Institute, The
Netherlands
Application of intravascular ultrasound (IVUS) is evolved rapidly and now we
